Title of article :
In vitro antifungal activities of Euphorbia macroclada and fluconazole against pathogenic Candida species
Author/Authors :
Mahmoudi ، S نويسنده Department of Medical Parasitology and Mycology, School of Publ ic Health, Tehran University of Medical Sciences, Tehran, Iran , , Roustaei ، M نويسنده Department of Medical Parasitology and Mycology, School of Publ ic Health, Tehran University of Medical Sciences, Tehran, Iran , , Zaini ، F نويسنده Department of Medical Parasitology and Mycology, School of Publ ic Health, Tehran University of Medical Sciences, Tehran, Iran , , Kordbacheh ، P نويسنده Department of Medical Parasitology and Mycology, School of Publ ic Health, Tehran University of Medical Sciences, Tehran, Iran , , Safara ، M نويسنده Department of Medical Parasitology and Mycology, School of Publ ic Health, Tehran University of Medical Sciences, Tehran, Iran ,
Issue Information :
فصلنامه با شماره پیاپی 0 سال 2015
Abstract :
Background and Purpose:
Candida
species constitute an important group of
opportunistic fungi,
which cause various
clinical diseases. Consider
ing the resistance of some
Candida
species to conventional antifungal agents, treatment of such
cases may be challenging and complicated. The purpose of this
study was to evaluate and
compare the antifungal activities
of
Euphorbia macroclada
latex and fluconazole against different
Candida
species.
Materials and Methods:
A total of 150
Candida
isolates including
C. albicans
(n=77),
C. glabrata (n=
28),
C.
parapsilosis
(n=23),
C. tropicalis
(n=15),
C. krusei
(n=4),
C. famata
(n=1),
C. kefyr
(n=1) and
C. inconspicua
(n=1)
were included in this study.
In vitro antifungal activities of
Euphorbia macroclada
latex and fluconazole against these
Candida
species were evaluated, according
to M27-A2 protocol on broth macrod
ilution method by the Clinical and
Laboratory Standards Institute (CLSI).
Results:
Among 150
Candida
isolates, 98 isolates (65.33%), i.e.,
C
.
albicans
(n=41),
C. glabrata
(n=23),
C. tropicalis
(n=12) and
C. parapsilosis
(n=22) with minimal inhibitory concentration
(MIC)
?
8
?
g/ml were susceptible to
fluconazole.
Resistance to fluconazole was
noted in 15 isolates, i.e.,
C. albicans
(n=10),
C. glabrata
(n=2),
C. krusei
(n=1),
C. kefyr
(n=1), and
C. inconspicua
(n=1), with MICs of 64 ?g/ml. The remaining isolates (n=37) including
C.
albicans
(n=26),
C. glabrata
(n=3),
C. tropicalis
(n=3),
C. parapsilosis
(n=1),
C. krusei
(n=3) and
C. famata
(n=1) with
MIC= 16-32 ?g/ml showed dose-dependent susceptibility. The latex of
Euphorbia macroclada
was able to inhibit the
growth of 30 out of 150 tested
Candida
isolates with MIC range of 128-512 ?g/ml. These isolates were as follows:
C.
albicans
(n=2),
C. glabrata
(n=4),
C. parapsilosis
(n=19),
C. krusei
(n=2) and
C. tropicalis
(n=3). Compared to other
isolates, higher MIC values were noted for
C. albicans
and
C. glabrata
(512 ?g/ml), respectively.
Conclusion:
The latex of
Euphorbia macroclada
showed notable antifungal activ
ities against some pathogenic
Candida
species. Therefore, it can be potentially used as an alterna
tive antifungal agent in future. However, further research is
required to identify its active components.
Journal title :
Current Medical Mycology
Journal title :
Current Medical Mycology